AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,219,581 | -13.0% | 17,450 | -23.2% | 0.03% | -20.5% |
| Q1 2023 | $1,402,110 | -24.1% | 22,732 | -5.1% | 0.04% | -25.0% |
| Q4 2022 | $1,847,649 | +475.6% | 23,955 | +181.6% | 0.05% | +160.0% |
| Q4 2021 | $321,000 | +49.3% | 8,508 | +30.6% | 0.02% | +17.6% |
| Q3 2021 | $215,000 | -74.1% | 6,515 | -35.5% | 0.02% | -70.7% |
| Q2 2020 | $831,000 | -51.5% | 10,102 | -65.3% | 0.06% | -53.2% |
| Q1 2020 | $1,713,000 | +616.7% | 29,120 | +1160.1% | 0.12% | +785.7% |
| Q4 2019 | $239,000 | -30.7% | 2,311 | -86.5% | 0.01% | -53.3% |
| Q3 2019 | $345,000 | +169.5% | 17,069 | -25.5% | 0.03% | +114.3% |
| Q4 2017 | $128,000 | – | 22,911 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,123,929 | $42,462,000 | 36.04% |
| MORGAN JESS S & CO INC | 114,525 | $4,327,000 | 2.66% |
| Fairmount Funds Management LLC | 187,598 | $7,087,000 | 2.34% |
| WMS Partners, LLC | 242,500 | $9,162,000 | 1.95% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 610,064 | $23,048,000 | 1.41% |
| MANGROVE PARTNERS IM, LLC | 400,000 | $15,112,000 | 0.90% |
| RTW INVESTMENTS, LP | 1,618,819 | $61,159,000 | 0.89% |
| MPM BioImpact LLC | 103,405 | $3,907,000 | 0.71% |
| Avidity Partners Management LP | 775,000 | $29,280,000 | 0.62% |
| FIRST MIDWEST BANK TRUST DIVISION | 115,028 | $4,346,000 | 0.56% |